FR128998 (a PAF receptor antagonist) counters the increased pulmonary vascular resistance associated with ischemia-reperfusion injury in the canine lung

International Journal of Angiology

Volumn 10, Issue 1, 2001, Pages 10-14

  Iwazaki, Shigeru ^a   Takeyoshi, Izumi ^a   Ohwada, Susumu ^a   Sunose, Yutaka ^a   Aiba, Masaaki ^a   Tsutsumi, Hirofumi ^a   Kawashima, Yoshiyuki ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 10 (3 PYRIDYLMETHYL) 7 THIA 10 AZASPIRO[5,6]DODECAN 11 ONE 7,7 DIOXIDE; FR 128998; HYALIN; THIAZEPINE DERIVATIVE; UNCLASSIFIED DRUG;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTERY CLAMP; ARTICLE; BRONCHUS; CELL INFILTRATION; CONTROLLED STUDY; DOG; HEART OUTPUT; HISTOPATHOLOGY; ISCHEMIA; LUNG ALVEOLUS; LUNG BLOOD FLOW; LUNG EDEMA; LUNG HEMODYNAMICS; LUNG HILUS; LUNG INJURY; LUNG ISCHEMIA; LUNG VASCULAR RESISTANCE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VEIN; REPERFUSION INJURY;

EID: 0035726246     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01616336     Document Type: Article

References (23)

1. Perspectives in platelet-activating factor research
2. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats
3. Platelet-activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone
4. A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation
5. 1
6. Donor administration of PAF Antagonist (TCV-309) enhances lung preservation
7. Platelet-activating factor antagonist enhances lung preservation
8. Long-term lung preservation with the PAF antagonist BN 52021
9. Single lung transplantation for pulmonary hypertension. Technical aspects and immediate hemodynamic results
10. Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia
11. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet-activating factor antagonist, in myocardial ischemia and reperfusion
12. Protective effects of L-659989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats
13. Platelet-activating factor plays an important role in reperfusion injury in myocardium
14. Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia
15. Pharmacologic modulation of experimental postischemic hepatic function
16. Platelet-activating factor in hepatic ischemia/reperfusion injury
17. Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbit
18. Effects of platelet-activating factor antagonist on preservation/reperfusion injury on the graft in porcine orthotopic liver transplantation
19. Platelet-activating factor (PAF) and tumor necrosis factor-α (TNFα) interactions in endotoxemic shock: Studies with BN 50739, a novel PAF antagonist
20. Effects of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation
21. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver
22. GMP-140, a receptor mediates interactions of leukocytes with activated platelet and endothelium
23. Priming by platelet-activating factor of neutrophil-induced impairment of endothelium-dependent relaxation